Literature DB >> 8487270

Gaucher's disease in the United Kingdom: screening non-Jewish patients for the two common mutations.

A J Walley1, M L Barth, I Ellis, A H Fensom, A Harris.   

Abstract

Twenty-six patients with Gaucher's disease diagnosed in the United Kingdom and two obligate carriers, all of non-Jewish origin, were screened for the two common disease causing mutations and two rarer mutations in the glucocerebrosidase gene. These mutations are referred to as N370S, L444P, Ins84G, and 1066 + 1G-->A, respectively. The results showed that out of 54 alleles screened, 26% were N370S, 35% were L444P, and the remaining 39% were rare or undefined. The results also showed a clear correlation between the presence of at least one N370S allele and mild disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8487270      PMCID: PMC1016332          DOI: 10.1136/jmg.30.4.280

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  13 in total

1.  High frequency of the Gaucher disease mutation at nucleotide 1226 among Ashkenazi Jews.

Authors:  A Zimran; T Gelbart; B Westwood; G A Grabowski; E Beutler
Journal:  Am J Hum Genet       Date:  1991-10       Impact factor: 11.025

2.  Genetic heterogeneity in type 1 Gaucher disease: multiple genotypes in Ashkenazic and non-Ashkenazic individuals.

Authors:  S Tsuji; B M Martin; J A Barranger; B K Stubblefield; M E LaMarca; E I Ginns
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

Review 3.  Gaucher disease: new molecular approaches to diagnosis and treatment.

Authors:  E Beutler
Journal:  Science       Date:  1992-05-08       Impact factor: 47.728

4.  Gene mapping and leader polypeptide sequence of human glucocerebrosidase: implications for Gaucher disease.

Authors:  E I Ginns; P V Choudary; S Tsuji; B Martin; B Stubblefield; J Sawyer; J Hozier; J A Barranger
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

5.  The human glucocerebrosidase gene and pseudogene: structure and evolution.

Authors:  M Horowitz; S Wilder; Z Horowitz; O Reiner; T Gelbart; E Beutler
Journal:  Genomics       Date:  1989-01       Impact factor: 5.736

6.  Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher disease.

Authors:  D Schnabel; M Schröder; K Sandhoff
Journal:  FEBS Lett       Date:  1991-06-17       Impact factor: 4.124

7.  Gaucher disease: molecular heterogeneity and phenotype-genotype correlations.

Authors:  B Theophilus; T Latham; G A Grabowski; F I Smith
Journal:  Am J Hum Genet       Date:  1989-08       Impact factor: 11.025

8.  A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease.

Authors:  S Tsuji; P V Choudary; B M Martin; B K Stubblefield; J A Mayor; J A Barranger; E I Ginns
Journal:  N Engl J Med       Date:  1987-03-05       Impact factor: 91.245

9.  Identification of the second common Jewish Gaucher disease mutation makes possible population-based screening for the heterozygous state.

Authors:  E Beutler; T Gelbart; W Kuhl; J Sorge; C West
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

10.  Molecular pathology of haemophilia B.

Authors:  P M Green; D R Bentley; R S Mibashan; I M Nilsson; F Giannelli
Journal:  EMBO J       Date:  1989-04       Impact factor: 11.598

View more
  5 in total

1.  Mutation analysis in 46 British and Irish patients with Gaucher's disease.

Authors:  C E Hatton; A Cooper; C Whitehouse; J E Wraith
Journal:  Arch Dis Child       Date:  1997-07       Impact factor: 3.791

Review 2.  The glucocerebrosidase locus in Gaucher's disease: molecular analysis of a lysosomal enzyme.

Authors:  P K Mistry; T M Cox
Journal:  J Med Genet       Date:  1993-11       Impact factor: 6.318

3.  The N370S mutation in the glucocerebrosidase gene of Portuguese type 1 Gaucher patients: linkage to the PvuII polymorphism.

Authors:  L Lacerda; O Amaral; R Pinto; J Aerts; M C Sá Miranda
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

4.  Molecular characterisation of type 1 Gaucher disease families and patients: intrafamilial heterogeneity at the clinical level.

Authors:  O Amaral; A M Fortuna; L Lacerda; R Pinto; M C Sa Miranda
Journal:  J Med Genet       Date:  1994-05       Impact factor: 6.318

5.  Variants associated with Gaucher disease in multiple system atrophy.

Authors:  Jun Mitsui; Takashi Matsukawa; Hidenao Sasaki; Ichiro Yabe; Masaaki Matsushima; Alexandra Dürr; Alexis Brice; Hiroshi Takashima; Akio Kikuchi; Masashi Aoki; Hiroyuki Ishiura; Tsutomu Yasuda; Hidetoshi Date; Budrul Ahsan; Atsushi Iwata; Jun Goto; Yaeko Ichikawa; Yasuo Nakahara; Yoshio Momose; Yuji Takahashi; Kenju Hara; Akiyoshi Kakita; Mitsunori Yamada; Hitoshi Takahashi; Osamu Onodera; Masatoyo Nishizawa; Hirohisa Watanabe; Mizuki Ito; Gen Sobue; Kinya Ishikawa; Hidehiro Mizusawa; Kazuaki Kanai; Takamichi Hattori; Satoshi Kuwabara; Kimihito Arai; Shigeru Koyano; Yoshiyuki Kuroiwa; Kazuko Hasegawa; Tatsuhiko Yuasa; Kenichi Yasui; Kenji Nakashima; Hijiri Ito; Yuishin Izumi; Ryuji Kaji; Takeo Kato; Susumu Kusunoki; Yasushi Osaki; Masahiro Horiuchi; Tomoyoshi Kondo; Shigeo Murayama; Nobutaka Hattori; Mitsutoshi Yamamoto; Miho Murata; Wataru Satake; Tatsushi Toda; Alessandro Filla; Thomas Klockgether; Ullrich Wüllner; Garth Nicholson; Sid Gilman; Caroline M Tanner; Walter A Kukull; Mathew B Stern; Virginia M-Y Lee; John Q Trojanowski; Eliezer Masliah; Phillip A Low; Paola Sandroni; Laurie J Ozelius; Tatiana Foroud; Shoji Tsuji
Journal:  Ann Clin Transl Neurol       Date:  2015-02-28       Impact factor: 4.511

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.